Literature DB >> 9427460

Characteristics of human immunodeficiency virus-infected children at the time of death: an experience in the 1990s.

R Johann-Liang1, J S Cervia, G J Noel.   

Abstract

OBJECTIVE: To describe the changes in the characteristics of human immunodeficiency virus (HIV)-related deaths in children with perinatally acquired infection.
METHODS: A retrospective review of all deaths that occurred in HIV-infected children managed at The New York Hospital-Program for Children with AIDS during a 7-year period from January, 1990, to December, 1996. Differences in the characteristics at death between 15 children who died in 1990 and 10 children who died in 1996 were analyzed.
RESULTS: Fifty-eight deaths in our cohort of HIV-infected children were identified during the 7-year period. The mean age at death was 4.43 years. Sixty-nine percent of children were black, 55% were male and 94% were receiving Medicaid. The mean weight/age Z score was -3.9 and the mean CD4 index was 0.067 with 65% having <50 CD4 cells/microl at the time of death (TOD). The most common organ/organ systems to be involved at the TOD were lung (78%) and central nervous system (61%). Mycobacterium avium complex (MAC) was the most common isolate at the TOD (26%) followed by Pneumocystis carinii (20%) and Pseudomonas aeruginosa (17%). The leading non-infectious cause of death was cardiac failure (9%). Comparison of the characteristics at the TOD between 1990 and 1996 revealed significant differences in mean age (2.1 vs. 9.2 years, P < 0.0001), mean CD4 count index (0.18 vs. 0.02, P < 0.03), mean number of organ/organ system involvement (3.9 vs. 5.9, P < 0.05), percent receiving antiretroviral therapy (33% vs. 70%, P < 0.02), mean number of years receiving antiretroviral therapy (0.88 vs. 3.86 years, P < 0.01), percent receiving P. carinii pneumonia prophylaxis (27% vs. 100%, P < 0.001), percent receiving MAC prophylaxis/therapy (0% vs. 100%, P < 0.0001), and cause of death from P. carinii pneumonia (53% vs. 0%, P < 0.01).
CONCLUSIONS: Compared with children who died in 1990, HIV-infected children who died in 1996 were significantly older, more lymphopenic and more likely to have a greater number of organ system involvements and to have received antiviral therapy and antimicrobial prophylaxis. In 1996 no child died of P. carinii pneumonia. In 1996 MAC and P. aeruginosa were the two most important opportunistic infections causing death. These changes in the characteristics at death will warrant review of resources used in treating these children and may be critical in advising parents and care givers about the prognosis of this chronic infection.

Entities:  

Mesh:

Year:  1997        PMID: 9427460     DOI: 10.1097/00006454-199712000-00009

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  9 in total

1.  Mortality trends in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).

Authors:  Bill G Kapogiannis; Minn M Soe; Steven R Nesheim; Elaine J Abrams; Rosalind J Carter; John Farley; Paul Palumbo; Linda J Koenig; Marc Bulterys
Journal:  Clin Infect Dis       Date:  2011-11       Impact factor: 9.079

Review 2.  Reporting of deaths during pre-approval clinical trials for advanced HIV-infected populations.

Authors:  Rosemary Johann-Liang; Andrea N James; Virginia L Behr; Kimberly Struble; Debra B Birnkrant
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

3.  Human immunodeficiency virus-related mortality in infants and children: data from the pediatric pulmonary and cardiovascular complications of vertically transmitted HIV (P(2)C(2)) Study.

Authors:  C Langston; E R Cooper; J Goldfarb; K A Easley; S Husak; S Sunkle; T J Starc; A A Colin
Journal:  Pediatrics       Date:  2001-02       Impact factor: 7.124

4.  Pseudomonas spp. complications in patients with HIV disease: an eight-year clinical and microbiological survey.

Authors:  R Manfredi; A Nanetti; M Ferri; F Chiodo
Journal:  Eur J Epidemiol       Date:  2000-02       Impact factor: 8.082

5.  The impact of HAART on cardiomyopathy among children and adolescents perinatally infected with HIV-1.

Authors:  Kunjal Patel; Russell B Van Dyke; Murray A Mittleman; Steven D Colan; James M Oleske; George R Seage
Journal:  AIDS       Date:  2012-10-23       Impact factor: 4.177

Review 6.  The role of protease inhibitor therapy in children with HIV infection.

Authors:  Patrick J Gavin; Ram Yogev
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 7.  Understanding the contribution of common childhood illnesses and opportunistic infections to morbidity and mortality in children living with HIV in resource-limited settings.

Authors:  Surbhi Modi; Alex Chiu; Bernadette Ng'eno; Scott E Kellerman; Nandita Sugandhi; Lulu Muhe
Journal:  AIDS       Date:  2013-11       Impact factor: 4.177

8.  Incidence of cardiac abnormalities in children with human immunodeficiency virus infection: The prospective P2C2 HIV study.

Authors:  Thomas J Starc; Steven E Lipshultz; Kirk A Easley; Samuel Kaplan; J Timothy Bricker; Steven D Colan; Wyman W Lai; Welton M Gersony; George Sopko; Douglas S Moodie; Mark D Schluchter
Journal:  J Pediatr       Date:  2002-09       Impact factor: 4.406

9.  Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era.

Authors:  Michael T Brady; James M Oleske; Paige L Williams; Carol Elgie; Lynne M Mofenson; Wayne M Dankner; Russell B Van Dyke
Journal:  J Acquir Immune Defic Syndr       Date:  2010-01       Impact factor: 3.731

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.